Increase In U.S. Global AIDS Funding, Domestic Spending Would Help Reach 90-90-90 Targets By 2022, Analysis Shows

aidsmap: U.S. HIV funding decisions on PEPFAR in 2017 will have critical effect on ability to reach 90-90-90 goals
“A [complete] withdrawal of United States funding for HIV treatment and prevention in sub-Saharan Africa could lead to 7.9 million additional HIV infections and almost 300,000 AIDS deaths between now and 2030, according to modeling of the impact of U.S. funding carried out by Imperial College, London, and presented last week at the 9th International AIDS Society Conference on HIV Science (IAS 2017) in Paris. … The modeling also showed that maintaining funding only at existing levels will lead to a flatlining of the proportion of people living with HIV who are on treatment and virally suppressed. On the other hand, if expansion of U.S. funding is accompanied by increases in domestic funding and more efficient allocation of funding within each country, there could be rapid progress towards the 90-90-90 target by 2022…” (Alcorn, 8/1).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.